| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |